BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9384802)

  • 1. Correlation between MIB-1 staining indices and recurrence in low-grade astrocytomas.
    Hoshi M; Yoshida K; Shimazaki K; Sasaki H; Otani M; Kawase T
    Brain Tumor Pathol; 1997; 14(1):47-51. PubMed ID: 9384802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
    Kirkegaard LJ; DeRose PB; Yao B; Cohen C
    Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
    Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular proliferation in pilocytic and diffuse astrocytomas.
    Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
    J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
    Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
    Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
    Machen SK; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
    Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
    J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
    Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
    Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children.
    Czech T; Slavc I; Aichholzer M; Haberler C; Dietrich W; Dieckmann K; Koos W; Budka H
    J Neurooncol; 1999 Apr; 42(2):143-50. PubMed ID: 10421072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIB-1 staining index of pediatric meningiomas.
    Sandberg DI; Edgar MA; Resch L; Rutka JT; Becker LE; Souweidane MM
    Neurosurgery; 2001 Mar; 48(3):590-5; discussion 595-7. PubMed ID: 11270550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma.
    McKeever PE; Strawderman MS; Yamini B; Mikhail AA; Blaivas M
    J Neuropathol Exp Neurol; 1998 Oct; 57(10):931-6. PubMed ID: 9786243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
    Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
    Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.
    Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T
    Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
    Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
    Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
    Patt S; Giraldo M; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: a study of 101 cases.
    Ho DM; Wong TT; Hsu CY; Ting LT; Chiang H
    Cancer; 1998 Jun; 82(12):2459-66. PubMed ID: 9635540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
    Prayson RA
    Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.